Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

Thursday’s Trading Day
11.73 +0.44 / +3.90%
As of Feb 11
Day’s Change
Friday’s Pre-Market   Switch to standard view »
11.81 +0.08 / +0.68%
Volume: 940.00
Health Technology

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-4000
Investor Relations:
(617) 274-4052



Individual stakeholders7.67%
Mutual fund holders30.62%
Other institutional28.60%

Top Executives

Edward M. KayeSenior VP, Chief Executive & Medical Officer
Sandesh MahatmeSenior VP, Chief Financial & Accounting Officer
Patrick L. IversenSenior Vice President-Research & Innovation
David Tyronne HowtonSecretary, Senior Vice President & General Counsel
Jayant AphaleSenior Vice President-Technical Operations